Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bivacor
AddedFeb 17, 2024
UpdatedJun 18, 2026
Bivacor

Bivacor

Series B

BiVACOR: A Houston-based, global medical tech firm, innovating with world-class specialists since 2008.

HQ
Houston, TX, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

BiVACOR, founded in 2008, is a privately held medical technology company headquartered in Houston, Texas, with an international office in Brisbane, Australia. The company's core mission is to revolutionize the treatment of heart failure through innovative solutions. BiVACOR focuses on developing a Total Artificial Heart (TAH) designed to provide a long-term solution for patients with severe heart failure. Their market focus includes the United States and Europe, where heart failure affects over 11 million people.

Notable figures affiliated with BiVACOR include world-class engineers, medical specialists, and business executives who contribute to its groundbreaking advancements. The company has received significant investment, including $13 million to support clinical trials for their TAH. BiVACOR's key achievements include establishing a strong collaborative network both nationally and internationally, positioning itself as a leader in the artificial heart market. Their work has the potential to impact thousands of patients who could benefit from advanced heart failure treatments.

Bivacor - Similar Companies

Bioventrix logo

Bioventrix

bioventrix.com

Vivifi Medical logo

Vivifi Medical

vivifimedical.com

Evaheart logo

Evaheart

evaheart-usa.com

Corveus Medical logo

Corveus Medical

corveusmedical.com

Viacor logo

Viacor

Cvrx logo

Cvrx

cvrx.com

Ancora Heart logo

Ancora Heart

ancoraheart.com

Corinnova logo

Corinnova

corinnova.com

ReliantHeart logo

ReliantHeart

reliantheart.com

Cardiovate logo

Cardiovate

Second Heart Assist logo

Second Heart Assist

secondheartinc.com

Corisma MCS Systems logo

Corisma MCS Systems

corismacv.com

Traverse Vascular logo

Traverse Vascular

Ventrinova logo

Ventrinova

Procyrion logo

Procyrion

Bivacor - Quick Facts

Who are Bivacor's competitors?

Companies similar to Bivacor include Bioventrix, Vivifi Medical, Evaheart and Corveus Medical.

When was Bivacor founded?

Bivacor was founded in 2008.

Where is Bivacor's headquarters located?

Bivacor's headquarters is located in Houston, TX, US.

When was Bivacor's last funding round?

Bivacor's most recent funding round was for $18M (USD) in March 2023.

How much has Bivacor raised to-date?

As of Mar 2, 2023, Bivacor has raised a total of $40M (USD).

How many employees does Bivacor have?

Bivacor has 25 employees as of Feb 5, 2024.

Bivacor - Classification

Industry
  • Hardware
Technology
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified